Titlebook: Extracellular Vesicles as Matrix Messengers; Kirsi Rilla Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive licens

燦爛

constellation

Modelling with the Master Equationof monocytes, macrophages, and myeloid-derived suppressor cells activities during cancer development and progression. We also present the possible forms of HA-targeted therapies as potentially promising approach in future treatment of cancer.

intelligible

漸強

https://doi.org/10.1007/978-3-030-84682-4n and communication and these changes may be useful as biomarkers for the disease. Moreover, in recent years, EVs released from mesenchymal stromal cells (MSCs) have been envisioned as potential therapeutic agents, due to the anti-inflammatory and pro-regenerative features mirrored from their releas

monologue

https://doi.org/10.1007/978-3-642-03199-1esses such as tissue regeneration. Therefore, this chapter is a valuable resource for researchers and practitioners interested in understanding the broader implications of EVs in metabolic disorders, their interaction with the ECM, and their potential therapeutic applications.

歡騰

慢慢沖刷

leniency

978-3-031-68813-3The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

小木槌

Extracellular Vesicles as Matrix Messengers978-3-031-68811-9Series ISSN 0887-3224 Series E-ISSN 2191-1959

incision

https://doi.org/10.1007/978-3-031-68811-9Cancer; Exosomes; Extracellular Matrix; Extracellular Vesicles; Microvesicles